Source: State of Ohio Board of Pharmacy
The Drug Enforcement Administration (DEA) is aware that during this pandemic there are obstacles to physicians meeting with their existing patients and providing these patients with written prescriptions for schedule II controlled substances.
As a result, physicians and pharmacists have asked the DEA to clarify the circumstances under which oral schedule II prescriptions are permitted. The DEA provides guidance on this topic and announces temporary exceptions.